EP0983357A1 - Modulatoren der geweberegeneration - Google Patents

Modulatoren der geweberegeneration

Info

Publication number
EP0983357A1
EP0983357A1 EP98923700A EP98923700A EP0983357A1 EP 0983357 A1 EP0983357 A1 EP 0983357A1 EP 98923700 A EP98923700 A EP 98923700A EP 98923700 A EP98923700 A EP 98923700A EP 0983357 A1 EP0983357 A1 EP 0983357A1
Authority
EP
European Patent Office
Prior art keywords
leu
ser
val
glu
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98923700A
Other languages
English (en)
French (fr)
Inventor
Michele Sanicola-Nadel
Catherine A. Hession
Henry Wei
Richard L. Cate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of EP0983357A1 publication Critical patent/EP0983357A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98923700A 1997-05-23 1998-05-22 Modulatoren der geweberegeneration Withdrawn EP0983357A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4749097P 1997-05-23 1997-05-23
US4749197P 1997-05-23 1997-05-23
US47490P 1997-05-23
US47491P 1997-05-23
PCT/US1998/010547 WO1998053071A1 (en) 1997-05-23 1998-05-22 Modulators of tissue regeneration

Publications (1)

Publication Number Publication Date
EP0983357A1 true EP0983357A1 (de) 2000-03-08

Family

ID=26725083

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98923700A Withdrawn EP0983357A1 (de) 1997-05-23 1998-05-22 Modulatoren der geweberegeneration

Country Status (5)

Country Link
EP (1) EP0983357A1 (de)
JP (1) JP2002516572A (de)
AU (1) AU7592998A (de)
CA (1) CA2290783A1 (de)
WO (1) WO1998053071A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040141975A1 (en) 1998-06-01 2004-07-22 Raitano Arthur B. Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
JP4855577B2 (ja) 1998-06-01 2012-01-18 アジェンシス，インコーポレイテッド ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用
US20060052321A1 (en) 2002-04-05 2006-03-09 Raitano Arthur B Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6451969B1 (en) 1999-01-15 2002-09-17 The Burnham Institute Methods for inhibiting tumor metastasis, and peptides useful therfor
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
US6717032B2 (en) 2000-07-06 2004-04-06 Deltagen, Inc Transgenic mice containing DEZ orphan receptor gene disruptions
WO2002003789A2 (en) * 2000-07-06 2002-01-17 Deltagen, Inc. Transgenic mice containing targeted gpcr gene disruptions
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
EP1436390A4 (de) * 2001-02-22 2005-07-20 Univ Rochester Retinoid-induzierbare proteine aus vaskulären glattmuskelzellen und deren verwendungen
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
AUPR470101A0 (en) 2001-05-02 2001-05-24 Murdoch Childrens Research Institute, The A molecular marker
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
EP2287186B1 (de) 2001-09-06 2014-12-31 Agensys, Inc. Nucleinsäure und entsprechendes Protein, STEAP-1, bei der Behandlung und zum Nachweis von Krebs
EP3000886A1 (de) 2003-03-19 2016-03-30 Amgen Fremont Inc. Antikörper gegen das t-zellen-immunglobulindomäne- und mucindomäne-1 (tim-1) antigen und verwendungen davon
BRPI0418766B8 (pt) 2004-04-22 2021-05-25 Agensys Inc anticorpo ou seu fragmento, vetor, composição farmacêutica, ensaio e método para detectar a presença de proteína steap-1, bem como método para distribuir um agente citotóxico ou um agente de diagnóstico
CA2629453C (en) 2005-11-10 2018-03-06 Curagen Corporation Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
EP2061814B1 (de) 2006-10-27 2012-06-06 Genentech, Inc. Antikörper und immunkonjugate sowie ihre verwendungen
SG183698A1 (en) 2007-08-20 2012-09-27 Oncotherapy Science Inc Cdca1 peptide and pharmaceutical agent comprising the same
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
WO2014010229A1 (en) 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Cdca1 epitope peptides for th1 cells and vaccines containing the same
CN110494452B (zh) 2017-04-03 2023-08-25 豪夫迈·罗氏有限公司 结合steap-1的抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026732A1 (en) * 1994-03-31 1995-10-12 Amur Research Corp. Diagnostic marker and method for determining renal function in mammals
US5552313A (en) * 1994-11-21 1996-09-03 Kansas University DNA encoding mouse phosphotriesterase-related protein
CA2257851C (en) * 1996-05-24 2011-11-15 Biogen, Inc. Modulators of tissue regeneration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9853071A1 *

Also Published As

Publication number Publication date
AU7592998A (en) 1998-12-11
CA2290783A1 (en) 1998-11-26
JP2002516572A (ja) 2002-06-04
WO1998053071A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
WO1998053071A1 (en) Modulators of tissue regeneration
US20030077809A1 (en) 97 human secreted proteins
KR20180011276A (ko) 잘못 접혀진 단백질의 분해를 위한 조성물 및 방법
US20040034192A1 (en) Human proteins having hyprophobic domains and dnas encoding these proteins
CZ299161B6 (cs) Polypeptid BAFF-R, nukleová kyselina kódující BAFF-R, protilátka proti BAFF-R a farmaceutické prípravky, které je obsahují
US20030027998A1 (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US20100291579A1 (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
CA2518101A1 (en) Compositions and methods for the treatment of systemic lupus erythematosis
WO2001016169A2 (en) RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE
US6713277B1 (en) Methods and composition for the diagnosis and treatment of body weight disorders, including obesity
US20030068784A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US20040048304A1 (en) 95 human secreted proteins
US20040110218A1 (en) BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes
US6790831B2 (en) Systemic carnitine deficiency gene and use thereof
JPH10313874A (ja) 腫瘍壊死因子受容体関連タンパク質ｔｒ５
US6706869B1 (en) Map kinase phosphatases and polynucleotides encoding them
JP2000512506A (ja) 新規化合物
JPH11253182A (ja) Ｇａｂａ ｂｐ ポリペプチドおよびポリヌクレオチド
US20020172995A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US20020142383A1 (en) Isolated nucleic acid molecules encoding human transport proteins
WO2001081412A2 (en) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
US20040235093A1 (en) Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof
US20030068691A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US20030088078A1 (en) 125 human secreted proteins
US20030166153A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19991221;LT PAYMENT 19991221;LV PAYMENT 19991221;MK PAYMENT 19991221;RO PAYMENT 19991221;SI PAYMENT 19991221

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20011201

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1026715

Country of ref document: HK